Development and Validation of a Predictive Nomogram of Disease Recurrence after Esophagectomy in Patients with Esophageal Squamous Cell Carcinoma Who Received Neoadjuvant Treatment

Development and Validation of a Predictive Nomogram of Disease Recurrence after Esophagectomy in Patients with Esophageal Squamous Cell Carcinoma Who Received Neoadjuvant Treatment - Development and Validation of a Predictive Nomogram of Disease Recurrence after Esophagectomy in Patients with Esophageal Squamous Cell Carcinoma Who Received Neoadjuvant Treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000048382

Enrollment

5000

Registered

2022-07-15

Start date

2021-09-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who received neoadjuvant treatment followed by curative surgery for esophageal cancer

Exclusion criteria

Exclusion criteria: Salvage surgery R1-2 resection

Design outcomes

Primary

Measure	Time frame
Disease Recurrence after Esophagectomy	—

Countries

Japan

Contacts

Public ContactAkihiko Okamura

Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan Department of Esophageal Surgery

akihiko.okamura@jfcr.or.jp0335200111

Outcome results